Entera Bio (ENTX) Short Interest Ratio & Short Volume → The #1 Crypto for AI (From Weiss Ratings) (Ad) Free ENTX Stock Alerts $2.30 -0.14 (-5.74%) (As of 05/20/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Entera Bio Short Interest DataCurrent Short Interest35,200 sharesPrevious Short Interest89,900 sharesChange Vs. Previous Month-60.85%Dollar Volume Sold Short$68,992.00Short Interest Ratio0.1 Days to CoverLast Record DateApril 30, 2024Outstanding Shares23,740,000 sharesPercentage of Shares Shorted∞Today's Trading Volume198,380 sharesAverage Trading Volume204,642 sharesToday's Volume Vs. Average97% Short Selling Entera Bio ? Sign up to receive the latest short interest report for Entera Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENTX Short Interest Over TimeENTX Days to Cover Over TimeENTX Percentage of Float Shorted Over Time Ad Stansberry ResearchWarren Buffett's "mystery stock"WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some Entera Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202435,200 shares $68,992.00 -60.9%N/A0.1 $1.96 4/15/202489,900 shares $226,548.00 +1.9%N/A0.4 $2.52 3/31/202488,200 shares $147,294.00 +988.9%N/A0.5 $1.67 3/15/20248,100 shares $11,097.00 +523.1%N/A0.1 $1.37 2/29/20241,300 shares $1,787.50 -95.0%N/A0 $1.38 2/15/202426,100 shares $27,405.00 +715.6%N/A0.3 $1.05 Get the Latest News and Ratings for ENTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Entera Bio and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,200 shares $2,655.36 -80.5%N/A0 $0.83 1/15/202416,400 shares $17,876.00 -73.9%0.1%0.2 $1.09 12/31/202362,800 shares $37,680.00 +5.7%0.3%1.2 $0.60 12/15/202359,400 shares $39,055.50 -13.0%0.3%1.7 $0.66 11/30/202368,300 shares $47,919.28 -3.1%0.3%2.1 $0.70 11/15/202370,500 shares $50,492.10 +29.6%0.3%2.1 $0.72 10/31/202354,400 shares $37,302.08 +8.8%0.3%1.3 $0.69 10/15/202350,000 shares $36,500.00 -16.0%0.2%1.2 $0.73 9/30/202359,500 shares $43,137.50 +18.3%0.3%1.5 $0.73 9/15/202350,300 shares $34,455.50 +89.1%0.2%1.3 $0.69 8/31/202326,600 shares $17,822.00 +24.9%0.1%0.8 $0.67 8/15/202321,300 shares $12,782.13 -42.7%0.1%0.6 $0.60 7/31/202337,200 shares $29,388.00 +268.3%0.2%1.3 $0.79 7/15/202310,100 shares $8,560.76 -55.5%0.1%0.3 $0.85 6/30/202322,700 shares $19,145.18 +291.4%0.1%0.7 $0.84 6/15/20235,800 shares $4,871.43 -82.3%0.0%0.1 $0.84 5/31/202332,800 shares $26,010.40 -12.8%0.2%0.5 $0.79 5/15/202337,600 shares $38,043.68 -23.7%0.2%0.2 $1.01 4/30/202349,300 shares $37,961.00 -54.5%0.2%0.2 $0.77 4/15/2023108,400 shares $92,627.80 -52.5%0.5%0.5 $0.85 3/31/2023228,200 shares $264,712.00 +22.8%1.0%1 $1.16 3/15/2023185,900 shares $187,759.00 +114.4%0.8%0.8 $1.01 2/28/202386,700 shares $77,683.20 +181.5%0.4%0.4 $0.90 2/15/202330,800 shares $29,059.80 -3.5%0.1%0.5 $0.94 1/31/202331,900 shares $29,284.23 -0.6%0.1%0.3 $0.92 1/15/202332,100 shares $26,643.00 -47.5%N/A0.3 $0.83 12/30/202261,100 shares $44,603.00 +8.5%N/A0.5 $0.73 12/15/202256,300 shares $35,294.47 -8.5%N/A0.5 $0.63 11/30/202261,500 shares $41,746.20 -43.4%N/A0.5 $0.68 11/15/2022108,700 shares $58,458.86 -26.6%N/A0.9 $0.54 10/31/2022148,100 shares $115,895.80 +119.7%N/A1.9 $0.78 10/15/202267,400 shares $56,616.00 +160.2%N/A1 $0.84 9/30/202225,900 shares $26,936.00 -54.8%N/A0.4 $1.04 9/15/202257,300 shares $76,209.00 +38.7%N/A1.7 $1.33Bill Clinton Backing Biden Replacement??? (Ad)Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August…Click here now for my urgent election forecast. 8/31/202241,300 shares $55,755.00 -5.9%N/A1.1 $1.35 8/15/202243,900 shares $77,703.00 -48.5%N/A1.4 $1.77 7/31/202285,300 shares $165,482.00 +9.1%N/A2.5 $1.94 7/15/202278,200 shares $109,480.00 -11.4%N/A2.4 $1.40 6/30/202288,300 shares $117,439.00 -30.3%N/A2.6 $1.33 6/15/2022126,700 shares $219,191.00 -14.7%N/A3.4 $1.73 5/31/2022148,600 shares $319,490.00 +4.2%N/A4.2 $2.15 5/15/2022142,600 shares $306,590.00 -1.7%N/A3.9 $2.15 4/30/2022145,000 shares $355,250.00 +10.1%N/A3.6 $2.45 4/15/2022131,700 shares $345,054.00 -24.7%N/A2.5 $2.62 3/31/2022174,800 shares $501,676.00 -13.1%N/A2.9 $2.87 3/15/2022201,200 shares $440,628.00 -2.5%N/A1.9 $2.19 2/28/2022206,400 shares $439,632.00 +12.7%N/A1.9 $2.13 2/15/2022183,200 shares $395,712.00 -31.6%N/A1.6 $2.16 1/31/2022267,800 shares $613,262.00 -11.0%N/A2.2 $2.29 1/15/2022300,800 shares $851,264.00 +7.4%N/A0 $2.83 12/31/2021280,000 shares $789,600.00 +9.3%N/A2.4 $2.82 12/15/2021256,300 shares $797,093.00 +5.4%N/A2.9 $3.11 11/30/2021243,100 shares $811,954.00 -16.8%N/A2.6 $3.34 11/15/2021292,200 shares $1.10 million -8.3%N/A2.8 $3.78 10/29/2021318,500 shares $1.36 million -3.7%N/A2.6 $4.26 10/15/2021330,800 shares $1.50 million -11.4%N/A2.1 $4.52 9/30/2021373,200 shares $1.76 million +21.3%N/A1.8 $4.71 9/15/2021307,600 shares $1.41 million -25.4%N/A0.7 $4.59 8/31/2021412,300 shares $2.01 million +119.5%N/A0.1 $4.88 8/13/2021187,800 shares $1.01 million +57.4%1.0%0.1 $5.40 7/30/2021119,300 shares $613,202.00 -33.3%0.6%0 $5.14 7/15/2021178,800 shares $935,124.00 -74.4%1.1%0.1 $5.23 6/30/2021697,100 shares $4.17 million +903.0%4.2%0.2 $5.98 6/15/202169,500 shares $259,235.00 -9.4%0.4%0 $3.73 5/28/202176,700 shares $247,741.00 -15.1%0.5%0 $3.23 5/14/202190,300 shares $263,676.00 -57.1%N/A0 $2.92 4/30/2021210,400 shares $715,360.00 +115.6%N/A0 $3.40 4/15/202197,600 shares $321,104.00 +21.1%N/A0 $3.29 3/31/202180,600 shares $265,980.00 -94.8%N/A0 $3.30 3/15/20211,540,000 shares $10.63 million +1,036.5%N/A0.2 $6.90 2/26/2021135,500 shares $239,835.00 -13.4%N/A0.2 $1.77 2/12/2021156,500 shares $284,830.00 +17.6%N/A0.2 $1.82 1/29/2021133,100 shares $185,009.00 -8.8%N/A0.2 $1.39 1/15/2021145,900 shares $180,916.00 +256.7%N/A0.3 $1.24 12/31/202040,900 shares $44,990.00 -17.4%0.4%0.1 $1.10 12/15/202049,500 shares $52,965.00 +56.7%0.5%0.1 $1.07 11/30/202031,600 shares $33,496.00 -41.2%0.3%0.3 $1.06 11/15/202053,700 shares $56,116.50 +42.1%0.5%0.6 $1.05 10/30/202037,800 shares $41,580.00 +7.4%0.4%0.3 $1.10 10/15/202035,200 shares $40,128.00 -49.9%0.3%0.2 $1.14 9/30/202070,300 shares $87,172.00 +174.6%0.7%0.1 $1.24 9/15/202025,600 shares $28,416.00 -42.3%0.2%0 $1.11 8/31/202044,400 shares $56,832.00 -28.2%0.4%0.1 $1.28 8/14/202061,800 shares $88,992.00 +8.8%0.6%0.1 $1.44**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report 7/31/202056,800 shares $95,992.00 +11.6%0.5%0.1 $1.69 7/15/202050,900 shares $91,111.00 +110.3%0.5%0.1 $1.79 6/30/202024,200 shares $45,254.00 +505.0%0.2%0.3 $1.87 6/15/20204,000 shares $7,440.00 +263.6%0.0%0.1 $1.86 5/29/20201,100 shares $2,200.00 -8.3%0.0%0 $2.00 5/15/20201,200 shares $2,664.00 -70.7%0.0%0 $2.22 4/30/20204,100 shares $9,348.00 +32.3%0.0%0.9 $2.28 4/15/20203,100 shares $7,254.00 -6.1%0.0%0.5 $2.34 3/31/20203,300 shares $6,468.00 +153.9%0.0%0.5 $1.96 3/13/20201,300 shares $2,782.00 No Change0.0%0.4 $2.14 2/28/20201,300 shares $2,665.00 -74.0%0.0%0.1 $2.05 2/14/20205,000 shares $14,250.00 -24.2%N/A0.4 $2.85 1/31/20206,600 shares $18,876.00 -35.9%0.1%0.5 $2.86 1/15/202010,300 shares $34,402.00 +281.5%0.1%0.8 $3.34 12/31/20192,700 shares $8,505.00 +800.0%0.1%0.2 $3.15 8/15/20195,600 shares $15,680.00 -13.9%0.2%0.4 $2.80 ENTX Short Interest - Frequently Asked Questions What is Entera Bio's current short interest? Short interest is the volume of Entera Bio shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 35,200 shares of ENTX short. Learn More on Entera Bio's current short interest. Is Entera Bio's short interest increasing or decreasing? Entera Bio saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 35,200 shares, a drop of 60.8% from the previous total of 89,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Entera Bio's short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Entera Bio: Atara Biotherapeutics, Inc. (9.87%), Protara Therapeutics, Inc. (5.00%), Instil Bio, Inc. (0.19%), Turnstone Biologics Corp. (5.22%), Cognition Therapeutics, Inc. (0.56%), Ikena Oncology, Inc. (5.99%), Precision BioSciences, Inc. (9.31%), Elutia Inc. (0.20%), Gritstone bio, Inc. (15.43%), Athira Pharma, Inc. (2.97%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Entera Bio stock? Short selling ENTX is an investing strategy that aims to generate trading profit from Entera Bio as its price is falling. ENTX shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Entera Bio? A short squeeze for Entera Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENTX, which in turn drives the price of the stock up even further. How often is Entera Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENTX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Atara Biotherapeutics Short Interest Data Protara Therapeutics Short Interest Data Instil Bio Short Interest Data Turnstone Biologics Short Interest Data Cognition Therapeutics Short Interest Data Ikena Oncology Short Interest Data Precision BioSciences Short Interest Data Elutia Short Interest Data Gritstone bio Short Interest Data Athira Pharma Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ENTX) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport SocietyThe #1 Crypto for AIWeiss RatingsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlace